Stereotaxis to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
February 04, 2021 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
Stereotaxis Reports 2020 Third Quarter Financial Results
November 09, 2020 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis to Report Third Quarter 2020 Financial Results on November 9, 2020
October 26, 2020 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
First Hospitals in the World Adopt Genesis Robotic Technology for Cardiac Heart Rhythm Disorders
September 14, 2020 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced it has...
Stereotaxis CEO Invited to Speak on Plenary Panel at RAPS Convergence 2020
September 08, 2020 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
Stereotaxis to Present at Three Investor Conferences in September
August 28, 2020 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...
Journal of American College of Cardiology Publishes Pioneering Study Using Stereotaxis Robotic Technology to Treat Pulmonary Hypertension
August 26, 2020 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a pioneering...
Stereotaxis Reports 2020 Second Quarter Financial Results
August 06, 2020 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis and Acutus Medical Announce First Integrated Cardiac Ablation Procedure with TeleRobotic Support
July 31, 2020 08:05 ET
|
Stereotaxis, Inc.
ST. LOUIS and CARLSBAD, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Acutus Medical today announced the first integrated cardiac ablation procedure benefiting from remote...
Stereotaxis to Report Second Quarter 2020 Financial Results on August 6, 2020
July 23, 2020 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 23, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...